Bioheart's Series A Round

Bioheart raised a round of funding on February 12, 2001. Investors include Tyco Ventures.

Bioheart is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.…

Articles about Bioheart's Series A Round: